Introduction

What is cardiac remodelling?

The act of changing or altering the structure, style, or form of something is called remodelling. Cardiac remodelling refers to changes in heart architecture (shape or size) after a disease, injury or damage. It includes any structural, functional, or molecular alterations happening in heart muscles, which can be either beneficial or detrimental.

Anatomy of the heart

The heart has four chambers: two upper atria and two lower ventricles. Blood from the body enters the right atrium, passes through the tricuspid valve into the right ventricle, and then travels to the lungs via the pulmonary valve. After picking up oxygen in the lungs, blood flows into the left atrium (LA), through the mitral valve into the left ventricle, and out to the body through the aortic valve.¹

What is left atrial enlargement?

When one of your heart chambers enlarges more than usual, it is known as left atrial enlargement (LAE). Over time, this occurs as your left atrium attempts to adapt to problems like elevated blood pressure in the rest of your heart. Your left atrium may enlarge and stretch in an attempt to compensate for this high pressure and/or high volume. It is frequently observed in diseases such as high blood pressure, mitral valve narrowing, thickening of the left ventricle, and diastolic heart dysfunction.²

Probable associations of left atrial enlargement (LAE)

Left atrial enlargement usually happens due to pressure or volume overload, or both. The size of the left atrium can reflect how severe or long-lasting this problem is. This is especially true when there are no other heart valve issues, like the mitral valve, affecting the results.²

Pressure overload

• Hypertension: a pathophysiological reaction to elevated afterload, chronic systemic hypertension causes left ventricular hypertrophy, which results in diastolic dysfunction
• Aortic stenosis: in the context of aortic stenosis, diastolic dysfunction and elevated afterload are the two main mechanisms that lead to LAE. Both lead to concentric left ventricular hypertrophy³
• Mitral stenosis: the left atrium may enlarge as a result of increased pressure brought on by both mitral stenosis (narrowing) and mitral regurgitation (leakage)
• Left ventricular (LV) dysfunction: patients with left ventricular failure frequently exhibit fibrosis and hypertrophy, two essential elements of structural remodelling in the left atrium⁴

Volume overload

• Mitral regurgitation: when blood leaks backwards into the left atrium, it increases the volume and can cause the atrium to enlarge. The amount of enlargement can vary depending on how the left ventricle is shaped and functions³
• Left-to-right shunts (like atrial septal defects (ASD)): these usually cause right atrial enlargement, not left atrial, because extra blood flows into the right side of the heart

Other causes

• Athlete's heart
• Arteriovenous fistulas (AVF): These abnormal connections between arteries and veins (whether present from birth or created for dialysis) can increase blood volume and pressure in the heart. This extra load can lead to LAE over time. In rare cases, AVF between the coronary arteries and the left atrium have also been reported to cause LAE 
• Obesity and ageing⁵

Pathophysiology of left atrial enlargement

Atrial remodelling, as used in the context of pathophysiology, describes changes in the atria caused by several varying causes as mentioned above, but is divided into two categories, roughly.²

• Acute remodelling occurs quickly within a week of being exposed to stress, and can often return to normal if the cause is treated
• Chronic remodelling takes longer to develop and usually causes permanent changes in the atria

The type, intensity, and duration of these external stressors determine how much the LA changes structurally and functionally. LAE is a powerful warning indicator for the onset of atrial fibrillation (AF) and frequently one of the earliest indications of heart damage brought on by high blood pressure.

Structural remodelling

Atrial structural remodelling involves scarring (fibrosis) and physical changes in the heart’s atria, leading to their enlargement. Although it is often seen in heart failure, any condition that causes scarring in the atria can lead to this.²

One key factor is a shift in how heart cells produce energy, as they begin to use less efficient pathways. During remodelling, they adopt a less effective, more primitive approach. This change alters the breakdown of fats and results in less energy being produced, which may have an impact on the left atrium's performance.

Certain hormones and proteins, such as angiotensin II (Ang II), aldosterone, transforming growth factor-beta (TGF-β), and platelet-derived growth factor (PDGF), are often found at higher levels. These substances encourage fibrosis in the atrium by increasing cell growth. 

Additionally, inflammation also plays a role. Chemicals like interleukins, C-reactive protein (CRP), and cytokines may contribute to these structural changes in the heart.

Electrical remodelling

Changes in the way electrical signals are produced and pass through the atria are referred to as electrical remodelling in the heart. These modifications may weaken the electrical activity of the heart, shorten the time between heartbeats, or disrupt the atria's power to contract.²

Changes in the proteins and ion channels that help in regulating the electrical flow of the heart cause this. For instance, the movement of potassium and calcium may be reduced, or the gap junctions - connections between heart cells - may not function correctly. As a result, the electrical signals from the heart become less coordinated.⁶

Left atrial enlargement in the context of cardiac remodelling

The body's reaction to volume overload results in the enlargement of the left atrium. In addition to providing short-term support for the heart, it is a sign of impending heart failure.

The heart functions as a tightly coordinated unit, so when one part is not working properly, it affects the performance of the others. In other words, dysfunction in one chamber or valve can lead to changes and stress in the rest of the heart. Left atrial enlargement frequently results from left ventricular (LV) dysfunction, and vice versa, abnormalities in the LA may cause or worsen LV dysfunction.^2,7 

The loss of regular atrial contractions, erratic heartbeats, and potentially elevated heart rates can all impair the ventricles' ability to fill with blood when an AF occurs. It increases atrial pressure and has the potential to accelerate the onset of heart failure, which is especially harmful to those who already have diastolic dysfunction.

What are some of the tests to diagnose left atrial enlargement?

• Electrocardiogram (ECG)
• Transthoracic echocardiogram (TTE) or transesophageal echocardiogram (TEE)
• Cardiac CT (computed tomography)
• Heart MRI

Therapeutic implications and management strategies

Treating underlying causes

Management begins with identifying and treating the underlying conditions contributing to LAE and AF, such as hypertension, valvular heart disease, or heart failure. Controlling these conditions can slow or even reverse atrial remodelling. For example, aggressive blood pressure control can reduce atrial strain. Surgical correction of valve diseases or closure of shunts can decrease volume and pressure overload on the left atrium.

Rhythm vs. rate control in AF

There are two general approaches taken in atrial fibrillation patients:

• Rate control focuses on controlling the heart rate without restoring the normal rhythm
• Rhythm control aims to restore normal sinus rhythm using drugs or procedures, benefiting LA remodelling when done early

Choosing between rate and rhythm control depends on the individual patient’s condition, symptom burden, duration of AF, and underlying heart structure.

Medical therapy and LA remodelling

• ACE inhibitors (ACEIs) and angiotensin receptor blockers (ARBs): these lower blood pressure and reduce the effects of the renin-angiotensin system, which contributes to fibrosis and structural remodelling in the left atrium
• Mineralocorticoid receptor antagonists (MRAs) (e.g. spironolactone): These drugs help reduce fibrosis and have been associated with favourable effects on atrial structure and function²

These medications are especially beneficial in patients with hypertension, heart failure, or structural heart disease.

Surgical and catheter-based interventions

• Left atrial reduction surgery: In select patients with severe LAE, particularly those undergoing other cardiac surgeries (e.g., mitral valve repair), surgical reduction of the LA size may be considered to improve rhythm control outcomes and reduce symptoms
• Catheter ablation: This is a minimally invasive procedure that targets and isolates the areas in the atrium responsible for triggering AF. Ablation has shown significant benefit in maintaining sinus rhythm and may lead to reverse remodelling of the LA over time, particularly in patients with paroxysmal or early persistent AF

These interventions are generally more effective when the LA is not excessively enlarged and when done early in the course of disease progression.²

Current developments and future research paths

Recent advancements in artificial intelligence (AI) and cardiac imaging are improving the assessment of LA structure and function. Techniques such as cardiac MRI and speckle-tracking echocardiography provide detailed insights into LA strain and reservoir function, facilitating the early identification of remodelling. AI-driven image analysis offers more precise and automated measurements, improving risk evaluation and diagnostic accuracy.

Fibrosis mapping is crucial for guiding atrial fibrillation therapies such as catheter ablation, particularly when performed with late gadolinium enhancement MRI. It helps identify areas of atrial scarring that may act as substrates for arrhythmias.

Ongoing clinical trials are investigating targeted therapies, like antifibrotic medications and molecular modulators, which focus on specific LA remodelling pathways. These studies indicate a change towards personalised, atrial-centred management approaches by aiming to decelerate or reverse structural alterations in the LA, reduce the impact of AF, and enhance results.

Summary

Cardiac remodelling entails alterations in the heart’s architecture following an illness or damage. Left atrial enlargement (LAE) happens when the left atrium grows due to difficulties such as high blood pressure, mitral valve problems, or dysfunction of the left ventricle. LAE can indicate the seriousness of these conditions. There are two forms of remodelling: acute, which may reverse if the underlying issue is addressed, and chronic, which leads to lasting alterations. Structural changes involve scarring and alterations in energy production within heart cells, while electrical remodelling influences the transmission of signals in the heart. LAE can be diagnosed through ECG, echocardiography, cardiac CT scans, or MRI of the heart. Management of left atrial enlargement (LAE) and atrial fibrillation (AF) begins with addressing underlying issues such as hypertension and heart disease. There are two methods: rate control that manages heart rate, and rhythm control that seeks to bring back a normal heart rhythm. Drugs such as ACE inhibitors and MRAs are advantageous, whereas surgical alternatives consist of left atrial reduction and catheter ablation. Recent progress in AI and cardiac imaging improves evaluation and therapy planning. Current trials are investigating targeted therapies to tailor management and enhance results in AF treatment.